These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 21383655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A.
    J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215
    [Abstract] [Full Text] [Related]

  • 3. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M.
    Clin Biochem; 2005 Jun 01; 38(6):552-7. PubMed ID: 15885236
    [Abstract] [Full Text] [Related]

  • 4. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
    Zhao W, Fakhoury M, Baudouin V, Maisin A, Deschênes G, Jacqz-Aigrain E.
    Ther Drug Monit; 2011 Dec 01; 33(6):681-7. PubMed ID: 22011724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS, Taylor PJ, Salm P, Morris RG.
    Ther Drug Monit; 2007 Oct 01; 29(5):584-91. PubMed ID: 17898648
    [Abstract] [Full Text] [Related]

  • 8. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
    LeGatt DF, Shalapay CE, Cheng SB.
    Clin Biochem; 2004 Nov 01; 37(11):1022-30. PubMed ID: 15498532
    [Abstract] [Full Text] [Related]

  • 9. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L, Cointault O, Marquet P, Josse AG, Lavit M, Saint-Marcoux F, Kamar N.
    Transpl Int; 2010 Feb 01; 23(2):227-30. PubMed ID: 19761555
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry.
    Keevil BG, McCann SJ, Cooper DP, Morris MR.
    Ann Clin Biochem; 2002 Sep 01; 39(Pt 5):487-92. PubMed ID: 12227855
    [Abstract] [Full Text] [Related]

  • 11. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP.
    Ther Drug Monit; 2013 Feb 01; 35(1):96-100. PubMed ID: 23191996
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions.
    Toole B, Gechtman C, Dreier J, Kuhn J, Gutierrez MR, Barrett A, Niederau C.
    Clin Lab; 2015 Feb 01; 61(9):1303-15. PubMed ID: 26554251
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I, Zochowska D, Sanko-Resmer J, Matuszewicz D, Paczek L.
    Transplant Proc; 2006 Feb 01; 38(1):94-6. PubMed ID: 16504673
    [Abstract] [Full Text] [Related]

  • 14. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R, Chusney G, Loucaidou M, James A, Stichbury J, Van Tromp J, Cairns T, Griffith M, Hakim N, McLean A, Palmer A, Papalois V, Taube D.
    Ther Drug Monit; 2006 Apr 01; 28(2):269-73. PubMed ID: 16628143
    [Abstract] [Full Text] [Related]

  • 15. Time of drug administration, CYP3A5 and ABCB1 genotypes, and analytical method influence tacrolimus pharmacokinetics: a population pharmacokinetic study.
    Musuamba FT, Mourad M, Haufroid V, Delattre IK, Verbeeck RK, Wallemacq P.
    Ther Drug Monit; 2009 Dec 01; 31(6):734-42. PubMed ID: 19855314
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment.
    Moscato D, Nonnato A, Adamo R, Vancheri M, Caropreso A.
    Clin Chim Acta; 2010 Jan 01; 411(1-2):77-80. PubMed ID: 19835852
    [Abstract] [Full Text] [Related]

  • 18. Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique.
    Ansermot N, Fathi M, Veuthey JL, Desmeules J, Rudaz S, Hochstrasser D.
    Clin Biochem; 2008 Jul 01; 41(10-11):910-3. PubMed ID: 18358833
    [Abstract] [Full Text] [Related]

  • 19. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P, Armstrong VW, Brunet M, Haufroid V, Holt DW, Johnston A, Kuypers D, Le Meur Y, Marquet P, Oellerich M, Thervet E, Toenshoff B, Undre N, Weber LT, Westley IS, Mourad M.
    Ther Drug Monit; 2009 Apr 01; 31(2):139-52. PubMed ID: 19177031
    [Abstract] [Full Text] [Related]

  • 20. A rapid, simple and sensitive liquid chromatography-tandem mass spectrometry method for routine clinical monitoring of tacrolimus with the Waters Masstrak™ immmunosuppressant kit.
    Guilhaumou R, Lacarelle B, Sampol-Manos E.
    Methods Find Exp Clin Pharmacol; 2010 Dec 01; 32(10):737-43. PubMed ID: 21225010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.